Psychotropic medications: a descriptive study of prescription trends in Tabriz, Iran, 2021-2022.

Journal: BMC psychiatry
PMID:

Abstract

INTRODUCTION: Mental disorders, such as anxiety and depression, significantly impacted global populations in 2019 and 2020, with COVID-19 causing a surge in prevalence. They affect 13.4% of the people worldwide, and 21% of Iranians have experienced them. Prescription analysis is critical for evaluating and improving medical care in a cost-effective manner. This study examined prescription patterns for psychotropic drugs in outpatient settings to improve the understanding of medication utilization in a variety of patients. It aimed to assist healthcare professionals in making well-informed decisions about drug prescriptions, a topic not much addressed in Iran.

Authors

  • Mostafa Farahbakhsh
    Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Islamic Republic of Iran.
  • Ali Fakhari
    Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Islamic Republic of Iran.
  • Ali Azimian
    Tabriz University of Medical Sciences, Tabriz, Islamic Republic of Iran.
  • Amin Khameneh
    Tabriz University of Medical Sciences, Tabriz, Islamic Republic of Iran.
  • Mahsa Matinkia
    Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Islamic Republic of Iran.
  • Ehsan Aghajani
    Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Islamic Republic of Iran. Cr.ehsan_aghajani1@yahoo.com.